vs
Acadia Healthcare Company, Inc.（ACHC）与Liberty Energy Inc.（LBRT）财务数据对比。点击上方公司名可切换其他公司
Liberty Energy Inc.的季度营收约是Acadia Healthcare Company, Inc.的1.2倍（$1.0B vs $829.0M），Liberty Energy Inc.净利率更高（2.2% vs 0.5%，领先1.7%），Acadia Healthcare Company, Inc.同比增速更快（7.5% vs 4.5%），过去两年Acadia Healthcare Company, Inc.的营收复合增速更高（2.0% vs -6.2%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
Liberty Energy Inc.是北美领先的能源服务供应商，专注为油气运营企业提供水力压裂及完井解决方案，服务覆盖美国主要页岩产区，供应低排放作业设备及定制化支持，帮助提升油气井生产效率。
ACHC vs LBRT — 直观对比
营收规模更大
LBRT
是对方的1.2倍
$829.0M
营收增速更快
ACHC
高出3.0%
4.5%
净利率更高
LBRT
高出1.7%
0.5%
两年增速更快
ACHC
近两年复合增速
-6.2%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $1.0B |
| 净利润 | $4.5M | $22.6M |
| 毛利率 | — | — |
| 营业利润率 | — | 2.2% |
| 净利率 | 0.5% | 2.2% |
| 营收同比 | 7.5% | 4.5% |
| 净利润同比 | -50.8% | — |
| 每股收益（稀释后） | $0.05 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCLBRT
| Q1 26 | $829.0M | $1.0B | ||
| Q4 25 | $821.5M | $1.0B | ||
| Q3 25 | $851.6M | $947.4M | ||
| Q2 25 | $869.2M | $1.0B | ||
| Q1 25 | $770.5M | $977.5M | ||
| Q4 24 | $774.2M | $943.6M | ||
| Q3 24 | $815.6M | $1.1B | ||
| Q2 24 | $796.0M | $1.2B |
净利润ACHCLBRT
| Q1 26 | $4.5M | $22.6M | ||
| Q4 25 | $-1.2B | $13.7M | ||
| Q3 25 | $36.2M | $43.1M | ||
| Q2 25 | $30.1M | $71.0M | ||
| Q1 25 | $8.4M | $20.1M | ||
| Q4 24 | $32.6M | $51.9M | ||
| Q3 24 | $68.1M | $73.8M | ||
| Q2 24 | $78.5M | $108.4M |
毛利率ACHCLBRT
| Q1 26 | — | — | ||
| Q4 25 | — | 20.6% | ||
| Q3 25 | — | 18.7% | ||
| Q2 25 | — | 22.1% | ||
| Q1 25 | — | 22.1% | ||
| Q4 24 | — | 21.4% | ||
| Q3 24 | — | 26.2% | ||
| Q2 24 | — | 27.9% |
营业利润率ACHCLBRT
| Q1 26 | — | 2.2% | ||
| Q4 25 | -142.4% | 1.9% | ||
| Q3 25 | 4.7% | -0.3% | ||
| Q2 25 | 5.8% | 3.6% | ||
| Q1 25 | 1.7% | 1.9% | ||
| Q4 24 | 4.9% | 2.6% | ||
| Q3 24 | 12.1% | 9.4% | ||
| Q2 24 | 13.4% | 12.2% |
净利率ACHCLBRT
| Q1 26 | 0.5% | 2.2% | ||
| Q4 25 | -143.3% | 1.3% | ||
| Q3 25 | 4.3% | 4.5% | ||
| Q2 25 | 3.5% | 6.8% | ||
| Q1 25 | 1.1% | 2.1% | ||
| Q4 24 | 4.2% | 5.5% | ||
| Q3 24 | 8.4% | 6.5% | ||
| Q2 24 | 9.9% | 9.3% |
每股收益（稀释后）ACHCLBRT
| Q1 26 | $0.05 | $0.14 | ||
| Q4 25 | $-12.98 | $0.08 | ||
| Q3 25 | $0.40 | $0.26 | ||
| Q2 25 | $0.33 | $0.43 | ||
| Q1 25 | $0.09 | $0.12 | ||
| Q4 24 | $0.36 | $0.31 | ||
| Q3 24 | $0.74 | $0.44 | ||
| Q2 24 | $0.85 | $0.64 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $699.1M |
| 总债务越低越好 | $2.5B | $7.1M |
| 股东权益账面价值 | $2.0B | $1.9B |
| 总资产 | $5.5B | $4.4B |
| 负债/权益比越低杠杆越低 | 1.29× | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资ACHCLBRT
| Q1 26 | $158.5M | $699.1M | ||
| Q4 25 | $133.2M | $27.6M | ||
| Q3 25 | $118.7M | $13.5M | ||
| Q2 25 | $131.4M | $19.6M | ||
| Q1 25 | $91.2M | $24.1M | ||
| Q4 24 | $76.3M | $20.0M | ||
| Q3 24 | $82.1M | $23.0M | ||
| Q2 24 | $77.2M | $30.0M |
总债务ACHCLBRT
| Q1 26 | $2.5B | $7.1M | ||
| Q4 25 | $2.5B | $246.6M | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | $190.5M | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
股东权益ACHCLBRT
| Q1 26 | $2.0B | $1.9B | ||
| Q4 25 | $1.9B | $2.1B | ||
| Q3 25 | $3.1B | $2.1B | ||
| Q2 25 | $3.1B | $2.0B | ||
| Q1 25 | $3.0B | $2.0B | ||
| Q4 24 | $3.1B | $2.0B | ||
| Q3 24 | $3.0B | $2.0B | ||
| Q2 24 | $3.0B | $1.9B |
总资产ACHCLBRT
| Q1 26 | $5.5B | $4.4B | ||
| Q4 25 | $5.5B | $3.6B | ||
| Q3 25 | $6.4B | $3.5B | ||
| Q2 25 | $6.3B | $3.4B | ||
| Q1 25 | $6.1B | $3.4B | ||
| Q4 24 | $6.0B | $3.3B | ||
| Q3 24 | $5.9B | $3.3B | ||
| Q2 24 | $5.7B | $3.2B |
负债/权益比ACHCLBRT
| Q1 26 | 1.29× | 0.00× | ||
| Q4 25 | 1.28× | 0.12× | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | 0.10× | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 13.1% |
| 现金转化率经营现金流/净利润 | 13.78× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACHCLBRT
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $195.4M | ||
| Q3 25 | $73.2M | $51.5M | ||
| Q2 25 | $133.5M | $170.6M | ||
| Q1 25 | $11.5M | $192.1M | ||
| Q4 24 | $116.7M | $177.3M | ||
| Q3 24 | $163.1M | $244.5M | ||
| Q2 24 | $171.1M | $248.2M |
自由现金流ACHCLBRT
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $-10.0M | ||
| Q3 25 | $-63.0M | $-67.2M | ||
| Q2 25 | $-34.2M | $33.1M | ||
| Q1 25 | $-163.2M | $58.2M | ||
| Q4 24 | $-86.8M | $-26.2M | ||
| Q3 24 | $-27.1M | $77.9M | ||
| Q2 24 | $16.9M | $112.2M |
自由现金流率ACHCLBRT
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | -1.0% | ||
| Q3 25 | -7.4% | -7.1% | ||
| Q2 25 | -3.9% | 3.2% | ||
| Q1 25 | -21.2% | 6.0% | ||
| Q4 24 | -11.2% | -2.8% | ||
| Q3 24 | -3.3% | 6.8% | ||
| Q2 24 | 2.1% | 9.7% |
资本支出强度ACHCLBRT
| Q1 26 | — | 13.1% | ||
| Q4 25 | 11.3% | 19.8% | ||
| Q3 25 | 16.0% | 12.5% | ||
| Q2 25 | 19.3% | 13.2% | ||
| Q1 25 | 22.7% | 13.7% | ||
| Q4 24 | 26.3% | 21.6% | ||
| Q3 24 | 23.3% | 14.6% | ||
| Q2 24 | 19.4% | 11.7% |
现金转化率ACHCLBRT
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 14.28× | ||
| Q3 25 | 2.02× | 1.20× | ||
| Q2 25 | 4.43× | 2.40× | ||
| Q1 25 | 1.37× | 9.55× | ||
| Q4 24 | 3.58× | 3.42× | ||
| Q3 24 | 2.39× | 3.31× | ||
| Q2 24 | 2.18× | 2.29× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
LBRT
暂无分部数据
